In our study, we found that the expression of ChemR23 was significantly decreased along with cognitive impairment at the 8th week after CCH, while treatment with either RvE1 or C-9 obviously prevented this impairment. The gene discussed is CMKLR1; the disease is columnar cell hyperplasia of the breast.